Results 141 to 150 of about 52,950,106 (199)

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice. [PDF]

open access: yesAntibiotics (Basel)
Gasanov VAO   +8 more
europepmc   +1 more source

Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. [PDF]

open access: yesACS Infect Dis, 2021
Lakshmaiah Narayana J   +9 more
europepmc   +1 more source

Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophages. [PDF]

open access: yesCell Tissue Res, 2020
Cirone KM   +7 more
europepmc   +1 more source

Human Cathelicidin Antimicrobial Peptide LL-37 Promotes Lymphangiogenesis in Lymphatic Endothelial Cells through the ERK and Akt Signaling Pathways

open access: yes
博士論文全文, 博士論文要旨, 最終試験結果の要旨, 論文審査の要旨LL-37, the only member of the cathelicidin family of cationic antimicrobial peptides in humans has been shown to exhibit a wide variety of biological actions in addition to its antimicrobial activity.
Yanagisawa, Takahiro   +2 more
core  

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections. [PDF]

open access: yesCent Eur J Immunol, 2018
Majewski K   +3 more
europepmc   +1 more source

Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37. [PDF]

open access: yesRespir Res, 2019
Tatsuta M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy